HNGE - Company ID 0001673743
The table below shows Hinge Health, Inc.'s income statement line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Revenue | $587.86M | $390.40M | $292.73M |
| Cost of revenue | $119.64M | $90.50M | $98.55M |
| Gross profit | $468.22M | $299.90M | $194.18M |
| R&D | $368.14M | $100.84M | $110.06M |
| SG&A | $329.50M | $63.91M | $67.02M |
| Operating income | -$546.37M | -$31.91M | -$130.51M |
| Income tax | $998.00K | $677.00K | -$405.00K |
Hinge Health, Inc. reported annual revenue of $587.86M for fiscal year 2025. That is up 50.6% from $390.40M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Net income |
| -$528.26M |
| -$11.93M |
| -$108.14M |
| EPS (diluted) | -$7.77 | -$0.88 | -$8.31 |